Investing in biotech: Where are we now and what is the outlook?

Potential implications of US elections on investors

The US Presidential elections have always represented a potentially pivotal moment for the global healthcare sector because of implications on drug pricing – and the recent elections have been no different.

Some investors are understandably concerned that the power to make legislative changes granted by the Democrats' clean sweep − gaining the Presidency, House of Representatives, and the Senate − could have negative implications for the healthcare sector. Biotech investors are more optimistic, with the caveat that in the short term there may be an element of headline risk. With the Democrats winning both of the Georgia run-offs in early January, each party now has 50 seats, and Vice President Kamala Harris will have the deciding vote, giving President Joe Biden the slimmest of majoritie...